These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11480099)

  • 1. Treating symptoms of female sexual arousal disorder with the Eros-Clitoral Therapy Device.
    Wilson SK; Delk JR; Billups KL
    J Gend Specif Med; 2001; 4(2):54-8. PubMed ID: 11480099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new non-pharmacological vacuum therapy for female sexual dysfunction.
    Billups KL; Berman L; Berman J; Metz ME; Glennon ME; Goldstein I
    J Sex Marital Ther; 2001; 27(5):435-41. PubMed ID: 11554204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients.
    Schroder M; Mell LK; Hurteau JA; Collins YC; Rotmensch J; Waggoner SE; Yamada SD; Small W; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1078-86. PubMed ID: 15752887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of the Female Intervention Efficacy Index (FIEI) as an immediate outcome measure of medical intervention to treat female sexual dysfunction.
    Berman LA; Berman JR; Werbin T; Chabra S; Goldstein I
    J Sex Marital Ther; 2001; 27(5):427-33. PubMed ID: 11554203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, placebo-controlled, double blind, crossover design trial of the efficacy and safety of Zestra for Women in women with and without female sexual arousal disorder.
    Ferguson DM; Steidle CP; Singh GS; Alexander JS; Weihmiller MK; Crosby MG
    J Sex Marital Ther; 2003; 29 Suppl 1():33-44. PubMed ID: 12735087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of vaginal surgery for stress urinary incontinence on female sexual function: is the use of polypropylene mesh detrimental?
    Shah SM; Bukkapatnam R; Rodríguez LV
    Urology; 2005 Feb; 65(2):270-4. PubMed ID: 15708036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Female sexual arousal disorder with and without a distress criterion: prevalence and correlates in a representative Czech sample.
    Weiss P; Brody S
    J Sex Med; 2009 Dec; 6(12):3385-94. PubMed ID: 19758283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A psychoeducational intervention for sexual dysfunction in women with gynecologic cancer.
    Brotto LA; Heiman JR; Goff B; Greer B; Lentz GM; Swisher E; Tamimi H; Van Blaricom A
    Arch Sex Behav; 2008 Apr; 37(2):317-29. PubMed ID: 17680353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study.
    Salonia A; Zanni G; Nappi RE; Briganti A; Dehò F; Fabbri F; Colombo R; Guazzoni G; Di Girolamo V; Rigatti P; Montorsi F
    Eur Urol; 2004 May; 45(5):642-8; discussion 648. PubMed ID: 15082208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective duplex Doppler ultrasonographic study in women with sexual arousal disorder to objectively assess genital engorgement induced by EROS therapy.
    Munarriz R; Maitland S; Garcia SP; Talakoub L; Goldstein I
    J Sex Marital Ther; 2003; 29 Suppl 1():85-94. PubMed ID: 12735092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Libido and orgasm in middle-aged woman.
    González M; Viáfara G; Caba F; Molina T; Ortiz C
    Maturitas; 2006 Jan; 53(1):1-10. PubMed ID: 16213679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of experimentally adopted sexual schemas on vaginal response and subjective sexual arousal: a comparison between women with sexual arousal disorder and sexually healthy women.
    Middleton LS; Kuffel SW; Heiman JR
    Arch Sex Behav; 2008 Dec; 37(6):950-61. PubMed ID: 18256919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial.
    Basson R; Brotto LA
    BJOG; 2003 Nov; 110(11):1014-24. PubMed ID: 14592587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of female sexual dysfunction symptoms and its relationship to quality of life: a Japanese female cohort study.
    Hisasue S; Kumamoto Y; Sato Y; Masumori N; Horita H; Kato R; Kobayashi K; Hashimoto K; Yamashita N; Itoh N
    Urology; 2005 Jan; 65(1):143-8. PubMed ID: 15667880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function.
    Rosen R; Brown C; Heiman J; Leiblum S; Meston C; Shabsigh R; Ferguson D; D'Agostino R
    J Sex Marital Ther; 2000; 26(2):191-208. PubMed ID: 10782451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On categorization and quantification of women's sexual dysfunctions: an epidemiological approach.
    Oberg K; Fugl-Meyer AR; Fugl-Meyer KS
    Int J Impot Res; 2004 Jun; 16(3):261-9. PubMed ID: 15184916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder.
    Caruso S; Agnello C; Intelisano G; Farina M; Di Mari L; Cianci A
    Urology; 2004 May; 63(5):955-9. PubMed ID: 15134988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sensitivity of event logs, self-administered questionnaires and photoplethysmography to detect treatment-induced changes in female sexual arousal disorder (FSAD) diagnosis.
    Rellini A; Meston C
    J Sex Med; 2006 Mar; 3(2):283-91. PubMed ID: 16490021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual dysfunction in women with hyperprolactinemia: a pilot study report.
    Kadioglu P; Yalin AS; Tiryakioglu O; Gazioglu N; Oral G; Sanli O; Onem K; Kadioglu A
    J Urol; 2005 Nov; 174(5):1921-5. PubMed ID: 16217346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlated genetic and non-shared environmental influences account for the co-morbidity between female sexual dysfunctions.
    Witting K; Santtila P; Rijsdijk F; Varjonen M; Jern P; Johansson A; von der Pahlen B; Alanko K; Sandnabba NK
    Psychol Med; 2009 Jan; 39(1):115-27. PubMed ID: 18366817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.